Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03320954 · ClinicalTrials.gov registry record · NA

Language Assessment and Treatment Following Acquired Brain Injury

A NA study, sponsored by University of Nebraska Lincoln.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT03320954 is a NA study that has completed, run by University of Nebraska Lincoln. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03320954, a NA study, has completed, sponsored by University of Nebraska Lincoln.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

People with acquired brain injury (ABI) often experience persistent language challenges that are subtle in nature and not readily observable to others. These challenges can have substantial negative effects on vocational and social endeavors despite their subtlety. Even though these challenges are prevalent in the ABI population, limited methods exist for quantifying and remediating them. The two purposes of Phase I of this research are to (a) explore methods of using event related potential (ERP) recordings to quantify language processing differences between people with and without ABI and (b) correlate behavioral observations from language tests with ERP findings. The purpose of Phase II is to explore the use of game-based, group activities as an intervention for people with ABI who experience word-retrieval challenges. The purpose of Phase III is to collect post-intervention data for comparison with Phase I data and provide evidence about the effectiveness of the intervention program.

Interventions

  • BEHAVIORAL Anomia treatment

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2017-10-25
Est. Completion 2019-11-14
Phase NA

Sponsor

University of Nebraska Lincoln

24 total trials

What the Registry Record Tells You About NCT03320954

The ClinicalTrials.gov registry entry for NCT03320954 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska Lincoln, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Anomia treatment is the first listed.

NCT03320954 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03320954 about?

NCT03320954 is a clinical study titled "Language Assessment and Treatment Following Acquired Brain Injury". People with acquired brain injury (ABI) often experience persistent language challenges that are subtle in nature and not readily observable to others. These challenges can have substantial negative effects on vocational and social endeavors despite their subtlety. Even though these challenges are p...

What is the current status of trial NCT03320954?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2017-10-25. Estimated completion is 2019-11-14.

What interventions are being tested in trial NCT03320954?

The interventions under investigation include: Anomia treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT03320954?

This trial is sponsored by University of Nebraska Lincoln, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.